Allulose: Still “The King” of Artificial Sweeteners

After speaking with founders from leading sugar-reduction innovators including DouxMatok (Incredo), Better Juice, Bonumose, BlueTree Technologies, and Ambrosia Bio; one theme was consistent.

Most sweeteners fail not on sweetness, but on functionality.

Stevia and monk fruit struggle with off-notes, polyols cause GI issues, aspartame faces regulatory caution, and even promising next-generation sugars often fall short in heat stability, bulking, or cost-efficiency.

Allulose remains the strongest solution because it tastes like sugar, behaves like sugar, and works across bakery, dairy, beverages, and confectionery all while being low-calorie, non-glycemic, and increasingly affordable thanks to major breakthroughs in production. Tagatose is emerging as the next big contender, but in real-world formulation readiness and scale, Allulose still rules.

What Our Report Provides

R&D and patent activity for Allulose has surged since 2015 led by innovators like ADM, CJ CheilJedang, Bonumose, Ambrosia Bio, and Savanna Ingredients.

• Allulose’s research momentum and cost-reduction breakthroughs
• Startup and corporate innovation mapping
• Challenges scientists are solving: stability, production efficiency, crystallization
• Comparisons with Tagatose, sugar alcohols, Stevia/Monk Fruit, and biotech sweeteners
• Technology readiness, formulation performance, and regulatory pathways

Perfect for R&D, formulation teams, ingredient strategists, and innovation leaders exploring next-gen sweetening systems.

Download the Report

Get the full analysis of Allulose and the most promising sugar-reduction technologies.